Mark Cabonce, MS, DABT, is a Principal Biocompatibility Scientist at Abbott, specializing in ISO10993 Biocompatibility with over 10 years of experience in medical device toxicology. Previously, they held roles at Monsanto, Pfizer Global R&D, and WuXi AppTec, where they provided expert guidance on biocompatibility strategies and authored numerous regulatory documents. Mark's career is marked by a commitment to mentorship and teamwork, emphasizing support for the next generation of scientists in the medical device industry. They obtained a Master’s degree in Biology from Saint Louis University.
This person is not in the org chart
This person is not in any teams
This person is not in any offices